Carlos H. Barrios, Gilberto Lopes, Mastura Md Yusof, Fidel Rubagumya et al.
In the past decade, oncologists worldwide have seen unprecedented advances in drug development and approvals but have also become increasingly cognizant of the rising costs of and increasing inequities in access to these therapies. These trends have resulted in the current problematic situation in w...
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar et al.
9002 Background: Conflicts of interest (COI) between oncologists and the pharmaceutical industry might considerably influence how the presentation of the research results is delivered, impacting treatment decisions, and policy-making.While there are regulations on reporting COI in high-income countr...